Sigma-1 receptor mediates acquisition of alcohol drinking and seeking behavior in alcohol-preferring rats

Behavioural Brain Research

Volumn 287, Issue , 2015, Pages 315-322

  Blasio, Angelo ^a   Valenza, Marta ^a   Iyer, Malliga R ^b   Rice, Kenner C ^b   Steardo, Luca ^c   Hayashi, T ^d   Cottone, Pietro ^a   Sabino, Valentina ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Seiwakai Nishikawa Hospital   (Japan)

Author keywords

Addiction; Ethanol; Intake; Rat; Reinforcement; Reward

Indexed keywords

BD 1063; DRUGS USED IN THE TREATMENT OF ADDICTION; SIGMA 1 OPIATE RECEPTOR; UNCLASSIFIED DRUG; 1-(2-(3,4-DICHLOROPHENYL)ETHYL)-4-METHYLPIPERAZINE; ALCOHOL; PIPERAZINE DERIVATIVE; SIGMA OPIATE RECEPTOR; SIGMA-1 RECEPTOR;

ADULT; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG EFFECT; FLUID INTAKE; FOOD INTAKE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REINFORCEMENT; WEIGHT GAIN; ANIMAL; ANTAGONISTS AND INHIBITORS; CENTRAL NUCLEUS (AMYGDALA); DRUG EFFECTS; DRUG SEEKING BEHAVIOR; DRUG THERAPY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ALCOHOL DRINKING; ANIMALS; CENTRAL AMYGDALOID NUCLEUS; DRUG-SEEKING BEHAVIOR; ETHANOL; MALE; NUCLEUS ACCUMBENS; PIPERAZINES; RATS; RATS, WISTAR; RECEPTORS, SIGMA;

EID: 84927725727     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2015.03.065     Document Type: Article

References (87)

1. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., Gilbert P.E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976, 197:517-532.
2. Quirion R., Bowen W.D., Itzhak Y., Junien J.L., Musacchio J.M., Rothman R.B., et al. A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 1992, 13:85-86.
3. Su T.P., London E.D., Jaffe J.H. Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems. Science 1988, 240:219-221.
4. Vaupel D.B. Naltrexone fails to antagonize the sigma effects of PCP and SKF 10,047 in the dog. Eur J Pharmacol 1983, 92:269-274.
5. Hanner M., Moebius F.F., Flandorfer A., Knaus H.G., Striessnig J., Kempner E., et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci USA 1996, 93:8072-8077.
6. Seth P., Fei Y.J., Li H.W., Huang W., Leibach F.H., Ganapathy V. Cloning and functional characterization of a sigma receptor from rat brain. J Neurochem 1998, 70:922-931.
7. Mei J., Pasternak G.W. Molecular cloning and pharmacological characterization of the rat sigma1 receptor. Biochem Pharmacol 2001, 62:349-355.
8. Hayashi T., Su T.P. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell 2007, 131:596-610.
9. Ault D.T., Radeff J.M., Werling L.L. Modulation of [3H]Dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor. J Pharmacol Exp Ther 1998, 284:553-560.
10. Gronier B., Debonnel G. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems. Eur J Pharmacol 1999, 368:183-196.
11. Skuza G., Kolasiewicz W. Repeated treatment with SA4503, a selective sigma1 receptor agonist, up-regulates alpha-adrenergic system. a behavioral study. Pol J Pharmacol 2001, 53:547-550.
12. Su T.P., Hayashi T. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. Curr Med Chem 2003, 10:2073-2080.
13. Weatherspoon J.K., Gonzalez-Alvear G.M., Frank A.R., Werling L.L. Regulation of [3H] dopamine release from mesolimbic and mesocortical areas of guinea pig brain by sigma receptors. Schizophr Res 1996, 21:51-62.
14. Hashimoto K. Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression. Prog Neurobiol 2013, 100:15-29.
15. Fujimoto M., Hayashi T., Urfer R., Mita S., Su T.P. Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor. Synapse 2012, 66:630-639.
16. Penas C., Pascual-Font A., Mancuso R., Fores J., Casas C., Navarro X. Sigma receptor agonist 2-(4-morpholinethyl)1 phenylcyclohexanecarboxylate (Pre084) increases GDNF and BiP expression and promotes neuroprotection after root avulsion injury. J Neurotrauma 2011, 28:831-840.
17. Hiramatsu M., Hoshino T. Involvement of kappa-opioid receptors and sigma receptors in memory function demonstrated using an antisense strategy. Brain Res 2004, 1030:247-255.
18. Hiramatsu M., Hoshino T. Improvement of memory impairment by (+)- and (-)-pentazocine via sigma, but not kappa opioid receptors. Brain Res 2005, 1057:72-80.
19. Meunier J., Demeilliers B., Celerier A., Maurice T. Compensatory effect by sigma1 (sigma1) receptor stimulation during alcohol withdrawal in mice performing an object recognition task. Behav Brain Res 2006, 166:166-176.
20. Hashimoto K., Fujita Y., Iyo M. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors. Neuropsychopharmacology 2007, 32:514-521.
21. Hiranita T., Soto P.L., Tanda G., Katz J.L. Reinforcing effects of sigma-receptor agonists in rats trained to self-administer cocaine. J Pharmacol Exp Ther 2010, 332:515-524.
22. Martin-Fardon R., Maurice T., Aujla H., Bowen W.D., Weiss F. Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward. Neuropsychopharmacology 2007, 32:1967-1973.
23. Matsumoto R.R., Liu Y., Lerner M., Howard E.W., Brackett D.J. Sigma receptors: potential medications development target for anti-cocaine agents. Eur J Pharmacol 2003, 469:1-12.
24. Maurice T., Martin-Fardon R., Romieu P., Matsumoto R.R. Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity. Neurosci Biobehav Rev 2002, 26:499-527.
25. Nguyen E.C., McCracken K.A., Liu Y., Pouw B., Matsumoto R.R. Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies. Neuropharmacology 2005, 49:638-645.
26. Maurice T., Casalino M., Lacroix M., Romieu P. Involvement of the sigma 1 receptor in the motivational effects of ethanol in mice. Pharmacol Biochem Behav 2003, 74:869-876.
27. Sabino V., Cottone P., Blasio A., Iyer M.R., Steardo L., Rice K.C., et al. Activation of sigma-receptors induces binge-like drinking in Sardinian alcohol-preferring rats. Neuropsychopharmacology 2011, 36:1207-1218.
28. Sabino V., Cottone P., Zhao Y., Steardo L., Koob G.F., Zorrilla E.P. Selective reduction of alcohol drinking in Sardinian alcohol-preferring rats by a sigma-1 receptor antagonist. Psychopharmacology (Berlin) 2009, 205:327-335.
29. Sabino V., Cottone P., Zhao Y., Iyer M.R., Steardo L., Steardo L., et al. The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking. Neuropsychopharmacology 2009, 34:1482-1493.
30. Sabino V., Kwak J., Rice K.C., Cottone P. Pharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking. Alcohol Clin Exp Res 2013, 37:635-643.
31. Sabino V., Cottone P., Koob G.F., Steardo L., Lee M.J., Rice K.C., et al. Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology (Berlin) 2006, 189:175-186.
32. Colombo G. ESBRA-Nordmann 1996 Award Lecture: ethanol drinking behaviour in Sardinian alcohol-preferring rats. Alcohol Alcohol 1997, 32:443-453.
33. Bohman M., Sigvardsson S., Cloninger C.R. Maternal inheritance of alcohol abuse cross-fostering analysis of adopted women. Arch Gen Psychiatry 1981, 38:965-969.
34. Cloninger C.R., Bohman M., Sigvardsson S. Inheritance of alcohol abuse cross-fostering analysis of adopted men. Arch Gen Psychiatry 1981, 38:861-868.
35. Prescott C.A., Kendler K.S. Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am J Psychiatry 1999, 156:34-40.
36. Sigvardsson S., Bohman M., Cloninger C.R. Replication of the Stockholm Adoption Study of alcoholism Confirmatory cross-fostering analysis. Arch Gen Psychiatry 1996, 53:681-687.
37. Giuliano C., Robbins T.W., Wille D.R., Bullmore E.T., Everitt B.J. Attenuation of cocaine and heroin seeking by mu-opioid receptor antagonism. Psychopharmacology (Berlin) 2013, 227:137-147.
38. Everitt B.J., Robbins T.W. Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour. Psychopharmacology (Berlin) 2000, 153:17-30.
39. Di Ciano P., Everitt B.J. Neuropsychopharmacology of drug seeking: insights from studies with second-order schedules of drug reinforcement. Eur J Pharmacol 2005, 526:186-198.
40. Goldberg S.R., Kelleher R.T., Morse W.H. Second-order schedules of drug injection. Fed Proc 1975, 34:1771-1776.
41. Kelleher R.T., Goldberg S.R. Fixed-interval responding under second-order schedules of food presentation or cocaine injection. J Exp Anal Behav 1977, 28:221-231.
42. de Costa B.R., He X.S., Linders J.T., Dominguez C., Gu Z.Q., Williams W., et al. Synthesis and evaluation of conformationally restricted N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamines at sigma receptors 2. Piperazines, bicyclic amines, bridged bicyclic amines, and miscellaneous compounds. J Med Chem 1993, 36:2311-2320.
43. Giuliano C., Robbins T.W., Nathan P.J., Bullmore E.T., Everitt B.J. Inhibition of opioid transmission at the mu-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacology 2012, 37:2643-2652.
44. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Academic Press/Elsevier, Amsterdam, Boston. 6th ed.
45. Bell R.L., Rodd Z.A., Lumeng L., Murphy J.M., McBride W.J. The alcohol-preferring P rat and animal models of excessive alcohol drinking. Addict Biol 2006, 11:270-288.
46. Ciccocioppo R. Genetically selected alcohol preferring rats to model human alcoholism. Curr Top Behav Neurosci 2013, 13:251-269.
47. Ciccocioppo R., Economidou D., Cippitelli A., Cucculelli M., Ubaldi M., Soverchia L., et al. Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addict Biol 2006, 11:339-355.
48. Ericson M., Blomqvist O., Engel J.A., Soderpalm B. Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine. Eur J Pharmacol 1998, 358:189-196.
49. Rezvani A.H., Overstreet D.H., Levin E.D., Rosenthal D.I., Kordik C.P., Reitz A.B., et al. Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats. Alcohol Clin Exp Res 2007, 31:57-63.
50. Suchankova P., Steensland P., Fredriksson I., Engel J.A., Jerlhag E. Ghrelin receptor (GHS-R1A) antagonism suppresses both alcohol consumption and the alcohol deprivation effect in rats following long-term voluntary alcohol consumption. PLoS One 2013, 8:e71284.
51. Steensland P., Simms J.A., Holgate J., Richards J.K., Bartlett S.E. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking. Proc Natl Acad Sci USA 2007, 104:12518-12523.
52. Brammer M.K., Gilmore D.L., Matsumoto R.R. Interactions between 3,4-methylenedioxymethamphetamine and sigma1 receptors. Eur J Pharmacol 2006, 553:141-145.
53. Ito R., Robbins T.W., Everitt B.J. Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nat Neurosci 2004, 7:389-397.
54. Bachtell R.K., Wang Y.M., Freeman P., Risinger F.O., Ryabinin A.E. Alcohol drinking produces brain region-selective changes in expression of inducible transcription factors. Brain Res 1999, 847:157-165.
55. Herring B.E., Mayfield R.D., Camp M.C., Alcantara A.A. Ethanol-induced Fos immunoreactivity in the extended amygdala and hypothalamus of the rat brain: focus on cholinergic interneurons of the nucleus accumbens. Alcohol Clin Exp Res 2004, 28:588-597.
56. Moller C., Wiklund L., Sommer W., Thorsell A., Heilig M. Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res 1997, 760:94-101.
57. Carelli R.M., Wightman R.M. Functional microcircuitry in the accumbens underlying drug addiction: insights from real-time signaling during behavior. Curr Opin Neurobiol 2004, 14:763-768.
58. Pecina S., Smith K.S., Berridge K.C. Hedonic hot spots in the brain. Neuroscientist 2006, 12:500-511.
59. Pennartz C.M., Groenewegen H.J., Lopes da Silva F.H. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog Neurobiol 1994, 42:719-761.
60. Koob G.F. Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 2003, 27:232-243.
61. Tupala E., Tiihonen J. Dopamine and alcoholism: neurobiological basis of ethanol abuse. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:1221-1247.
62. Alonso G., Phan V., Guillemain I., Saunier M., Legrand A., Anoal M., et al. Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience 2000, 97:155-170.
63. Bouchard P., Quirion R. [3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes. Neuroscience 1997, 76:467-477.
64. Phan V.L., Urani A., Sandillon F., Privat A., Maurice T. Preserved sigma1 (sigma1) receptor expression and behavioral efficacy in the aged C57BL/6 mouse. Neurobiol Aging 2003, 24:865-881.
65. Hansson A.C., Cippitelli A., Sommer W.H., Ciccocioppo R., Heilig M. Region-specific down-regulation of Crhr1 gene expression in alcohol-preferring msP rats following ad lib access to alcohol. Addict Biol 2007, 12:30-34.
66. Katner S.N., Weiss F. Neurochemical characteristics associated with ethanol preference in selected alcohol-preferring and -nonpreferring rats: a quantitative microdialysis study. Alcohol Clin Exp Res 2001, 25:198-205.
67. Weiss F., Lorang M.T., Bloom F.E., Koob G.F. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol Exp Ther 1993, 267:250-258.
68. Zhou Y., Colombo G., Gessa G.L., Kreek M.J. Effects of voluntary alcohol drinking on corticotropin-releasing factor and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats. Neurosci Lett 2013, 554:110-114.
69. Koob G.F. Animal models of craving for ethanol. Addiction 2000, 95(Suppl 2):S73-S81.
70. Li T.K. Clinical perspectives for the study of craving and relapse in animal models. Addiction 2000, 95(Suppl 2):S55-S60.
71. Boening J.A., Lesch O.M., Spanagel R., Wolffgramm J., Narita M., Sinclair D., et al. Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials. Alcohol Clin Exp Res 2001, 25. 127S-31S.
72. McBride W.J., Le A.D., Noronha A. Central nervous system mechanisms in alcohol relapse. Alcohol Clin Exp Res 2002, 26:280-286.
73. Goldstein S.R., Matsumoto R.R., Thompson T.L., Patrick R.L., Bowen W.D., Walker J.M. Motor effects of two sigma ligands mediated by nigrostriatal dopamine neurons. Synapse 1989, 4:254-258.
74. Ceci A., Smith M., French E.D. Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic. Eur J Pharmacol 1988, 154:53-57.
75. Gundlach A.L., Largent B.L., Snyder S.H. Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J Neurosci 1986, 6:1757-1770.
76. Weissman A.D., Su T.P., Hedreen J.C., London E.D. Sigma receptors in post-mortem human brains. J Pharmacol Exp Therap 1988, 247:29-33.
77. Bastianetto S., Rouquier L., Perrault G., Sanger D.J. DTG-induced circling behaviour in rats may involve the interaction between sigma sites and nigro-striatal dopaminergic pathways. Neuropharmacology 1995, 34:281-287.
78. Iyengar S., Dilworth V.M., Mick S.J., Contreras P.C., Monahan J.B., Rao T.S., et al. Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors. Brain Res 1990, 524:322-326.
79. Weiser S.D., Patrick S.L., Mascarella S.W., Downing-Park J., Bai X., Carroll F.I., et al. Stimulation of rat striatal tyrosine hydroxylase activity following intranigral administration of sigma receptor ligands. Eur J Pharmacol 1995, 275:1-7.
80. Minabe Y., Matsuno K., Ashby C.R. Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. Synapse 1999, 33:129-140.
81. Sanchez-Arroyos R., Guitart X. Electrophysiological effects of E-5842, a sigma1 receptor ligand and potential atypical antipsychotic, on A9 and A10 dopamine neurons. Eur J Pharmacol 1999, 378:31-37.
82. Ikemoto S., McBride W.J., Murphy J.M., Lumeng L., Li T.K. 6-OHDA-lesions of the nucleus accumbens disrupt the acquisition but not the maintenance of ethanol consumption in the alcohol-preferring P line of rats. Alcohol Clin Exp Res 1997, 21:1042-1046.
83. Ito R., Dalley J.W., Howes S.R., Robbins T.W., Everitt B.J. Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J Neurosci 2000, 20:7489-7495.
84. Di Ciano P., Everitt B.J. Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior. Neuropsychopharmacology 2001, 25:341-360.
85. Kim H.W., Roh D.H., Yoon S.Y., Seo H.S., Kwon Y.B., Han H.J., et al. Activation of the spinal sigma-1 receptor enhances NMDA-induced pain via PKC- and PKA-dependent phosphorylation of the NR1 subunit in mice. Br J Pharmacol 2008, 154:1125-1134.
86. Yoon S.Y., Roh D.H., Seo H.S., Kang S.Y., Moon J.Y., Song S., et al. An increase in spinal dehydroepiandrosterone sulfate (DHEAS) enhances NMDA-induced pain via phosphorylation of the NR1 subunit in mice: involvement of the sigma-1 receptor. Neuropharmacology 2010, 59:460-467.
87. Wang D., Noda Y., Tsunekawa H., Zhou Y., Miyazaki M., Senzaki K., et al. Role of N-methyl-d-aspartate receptors in antidepressant-like effects of sigma 1 receptor agonist 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride (SA-4503) in olfactory bulbectomized rats. J Pharmacol Exp Ther 2007, 322:1305-1314.